ÂÜÀòÂÒÂ×

Shiyang Wang, M.D., Ph.D., is a clinical development executive with extensive experience in oncology, currently serving as the Director of Clinical Development for Solid Tumor at BeiGene. Previous roles include Study Physician at Boehringer Ingelheim, Associate Medical Director in Clinical Development at Deciphera Pharmaceuticals, and Project Portfolio Manager at Memorial Sloan Kettering Cancer Center. Shiyang Wang began a career in research coordination at New York University Langone Medical Center. Educational qualifications include a Doctor of Philosophy in Molecular Medicine from Cornell University and a medical degree equivalent from Shanghai JiaoTong University School of Medicine.